Key result
Extreme obesity (BMI >32) was associated with a significantly higher rate of 6-month target vessel revascularization following PCI compared to lower BMI categories (11.3% vs 8.5%, P=0.007).
Why the study?
Does obesity affect ischemic outcomes and bleeding in patients undergoing coronary stent placement with GP IIb/IIIa inhibitors?
Population
Patients undergoing planned coronary stent placement with routine use of glycoprotein IIb/IIIa inhibitors
Comparison
Obesity, extreme obesity, or morbid obesity vs Nonobese patients
Design
Cohort
Follow-up
6 months
Authors
Loading...
Extreme obesity was associated with higher TVR post-stenting; leaves open whether BMI-targeted strategies improve outcomes in younger patients.
Cohort
Yes
Does obesity affect ischemic outcomes and bleeding in patients undergoing coronary stent placement with GP IIb/IIIa inhibitors?
Absolute Event Rate: 11.3% vs 8.5%
p-value: p=0.007
Extreme obesity is associated with increased 6-month target vessel revascularization following coronary stenting, though obesity overall is associated with less major bleeding.
Martin et al. (2006) conducted a cohort in Coronary artery disease requiring stent placement. Extreme obesity (BMI > 32) vs. Non-extremely obese patients was evaluated on 6-month target vessel revascularization (TVR) (p=0.007). Extreme obesity (BMI >32) was associated with a significantly higher rate of 6-month target vessel revascularization following PCI compared to lower BMI categories (11.3% vs 8.5%, P=0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: